TrialThe Lancet. Neurology2020

Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial.

Tali Cukierman-Yaffe et al.PubMed ↗Publisher ↗

No numbers read from the abstract.